Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01FX14 L01FX14 Polatuzumab vedotin
L01FX15 L01FX15 Belantamab mafodotin
L01FX16 L01FX16 Oportuzumab monatox
L01FX17 L01FX17 Sacituzumab govitecan
L01FX18 L01FX18 Amivantamab
L01FX19 L01FX19 Sabatolimab
L01FX20 L01FX20 Trémélimumab
L01FX21 L01FX21 Naxitamab
L01FX22 L01FX22 Loncastuximab tesirine
L01FX23 L01FX23 Tisotumab vedotin
L01FX24 L01FX24 Teclistamab
L01FX25 L01FX25 Mosunetuzumab
L01FX26 L01FX26 Mirvetuximab soravtansine
L01FX27 L01FX27 Epcoritamab
L01FX28 L01FX28 Glofitamab
L01FX29 L01FX29 Talquetamab
L01FX31 L01FX31 Zolbetuximab
L01FX32 L01FX32 Elranatamab
L01FX33 L01FX33 Tarlatamab
L01FX34 L01FX34 Odronextamab
L01FX35 L01FX35 Datopotamab deruxtecan
L01FX36 L01FX36 Patritumab deruxtecan
L01FY L01FY Combinations of monoclonal antibodies and antibody drug conjugates
L01FY01 L01FY01 Pertuzumab and trastuzumab
L01FY02 L01FY02 Nivolumab and Relatlimab
L01FY03 L01FY03 Prolgolimab and Nurulimab
L01X L01X Other antineoplastic agents
L01XA L01XA Platinum compounds
L01XA01 L01XA01 Cisplatin
L01XA02 L01XA02 Carboplatin
Showing 30 of 6884 Records